How can we tell if a depression treatment works beyond placebo? A new real-world method measuring placebo shows that ...

Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor designed to address the core symptoms of ADHD in children and adults.

Testosterone Replacement Therapy (TRT) has emerged as a critical treatment for men experiencing low testosterone levels, a ...

The new report examined numbers from 2023, the latest year for which data were available. Deaths from cardiovascular diseases totaled 916,000, including about 680,000 deaths from heart disease and 180 ...

Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.

Dyne Therapeutics leverages its FORCE platform to target genetically driven muscle diseases. Read why I am bullish about DYN ...

An international task force of medical experts recently proposed major revisions to the way doctors measure treatment success for a common–and often severe–skin complication of stem cell ...

On January 23, 2026, Sanofi reported new phase 3 data showing that its investigational monoclonal antibody amlitelimab, which targets OX40-ligand without depleting T cells, delivered a strong efficacy ...

Nearly two decades after the Council of Yukon First Nations first released a report calling for a cancer strategy, the Yukon ...

New report shows growing use of medications, such as chemotherapy, immunotherapy, and hormone therapy, given before surgery ...

Eluned Morgan’s forty-ninth session as first minister comes to a close. Plaid Cymru MS Adam Price seeks the Welsh ...

Study should "offer relief" to patients who need long-term therapy for acid-related disord ...